person · Reporting owner
MONTANOVA CAPITAL, LLC
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Benitec Biopharma Inc.BNTC · Entity 5596 | Director · 10% owner | December 23, 2025 | December 30, 2025 |
| Veradermics, IncMANE · Entity 1907 | Director | August 19, 2026 | August 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Benitec Biopharma Inc.
Report date December 23, 2025 · Filed December 30, 2025
Jointly reported with Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 9,620,075 |
Reported balance
After 2025-12-23 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-12-23 · Purchase · Acquired 42,600 · Balance 9,620,075 F2: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 1,834,053 |
Reported balance
After 2025-12-23 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2025-12-23 · Purchase · Acquired 7,400 · Balance 1,834,053 F3: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 9,634,395 |
Reported balance
After 2025-12-26 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2025-12-26 · Purchase · Acquired 14,320 · Balance 9,634,395 F4: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 1,836,569 |
Reported balance
After 2025-12-26 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2025-12-26 · Purchase · Acquired 2,516 · Balance 1,836,569 F5: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 9,700,195 |
Reported balance
After 2025-12-29 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2025-12-29 · Purchase · Acquired 65,800 · Balance 9,700,195 F6: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 1,848,156 |
Reported balance
After 2025-12-29 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2025-12-29 · Purchase · Acquired 11,587 · Balance 1,848,156 F7: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
Filing footnotes · ownership attribution and instrument terms
F1: Notes are included on Exhibit 99.1.
F2: Notes are included on Exhibit 99.1.
F3: Notes are included on Exhibit 99.1.
F4: Notes are included on Exhibit 99.1.
F5: Notes are included on Exhibit 99.1.
F6: Notes are included on Exhibit 99.1.
F7: Notes are included on Exhibit 99.1.
Veradermics, Inc
Report date August 19, 2026 · Filed August 21, 2026
Jointly reported with Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.00001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 2,957,937 |
Reported balance
After 2026-08-19 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-08-19 · Sale · Disposed 690,601 · Balance 2,957,937 F2: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
| Common stock, par value $0.00001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 461,033 |
Reported balance
After 2026-08-19 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2026-08-19 · Sale · Disposed 59,399 · Balance 461,033 F3: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
| Common stock, par value $0.00001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 3,106,937 |
Reported balance
After 2026-08-20 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2026-08-20 · Other · Acquired 149,000 · Balance 3,106,937 F4: Notes are included on Exhibit 99.1. F6: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
| Common stock, par value $0.00001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 612,033 |
Reported balance
After 2026-08-20 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2026-08-20 · Other · Acquired 151,000 · Balance 612,033 F5: Notes are included on Exhibit 99.1. F6: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
| Pre-Funded WarrantsSEC Table II · derivative / convertible security | IndirectSee footnotes | 0 |
Reported balance
After 2026-08-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-20 · Other · Disposed 149,000 · Balance 0 F6: Notes are included on Exhibit 99.1. F4: Notes are included on Exhibit 99.1. F7: Notes are included on Exhibit 99.1. F8: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
| Pre-Funded WarrantsSEC Table II · derivative / convertible security | IndirectSee footnotes | 0 |
Reported balance
After 2026-08-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-20 · Other · Disposed 151,000 · Balance 0 F6: Notes are included on Exhibit 99.1. F5: Notes are included on Exhibit 99.1. F7: Notes are included on Exhibit 99.1. F8: Notes are included on Exhibit 99.1. F1: Notes are included on Exhibit 99.1. |
Filing footnotes · ownership attribution and instrument terms
F1: Notes are included on Exhibit 99.1.
F2: Notes are included on Exhibit 99.1.
F3: Notes are included on Exhibit 99.1.
F4: Notes are included on Exhibit 99.1.
F5: Notes are included on Exhibit 99.1.
F6: Notes are included on Exhibit 99.1.
F7: Notes are included on Exhibit 99.1.
F8: Notes are included on Exhibit 99.1.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2026 Filed Aug 21, 2026 22:11 UTC | Veradermics, Inc MANE · Entity 1907 | OtherPre-Funded Warrants · Derivative | 151,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-26-000947 · form4.xml · derivative · entry 6 MONTANOVA CAPITAL, LLC · CIK 0001569064 · Director Cowen Aaron · CIK 0001869640 · See footnotes Averill Master Fund, Ltd. · CIK 0001939329 · Director Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 151,000 shares Expires not disclosed F6 · derivative.exercise_price: Notes are included on Exhibit 99.1. F5 · shares: Notes are included on Exhibit 99.1. F7 · derivative.exercise_date: Notes are included on Exhibit 99.1. F8 · derivative.exercise_date: Notes are included on Exhibit 99.1. F7 · derivative.expiration_date: Notes are included on Exhibit 99.1. F7 · derivative.underlying_shares: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F5 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 22:11 UTC | Veradermics, Inc MANE · Entity 1907 | OtherPre-Funded Warrants · Derivative | 149,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-26-000947 · form4.xml · derivative · entry 5 MONTANOVA CAPITAL, LLC · CIK 0001569064 · Director Cowen Aaron · CIK 0001869640 · See footnotes Averill Master Fund, Ltd. · CIK 0001939329 · Director Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 149,000 shares Expires not disclosed F6 · derivative.exercise_price: Notes are included on Exhibit 99.1. F4 · shares: Notes are included on Exhibit 99.1. F7 · derivative.exercise_date: Notes are included on Exhibit 99.1. F8 · derivative.exercise_date: Notes are included on Exhibit 99.1. F7 · derivative.expiration_date: Notes are included on Exhibit 99.1. F7 · derivative.underlying_shares: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F4 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 22:11 UTC | Veradermics, Inc MANE · Entity 1907 | OtherCommon stock, par value $0.00001 per share | 151,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000947 · form4.xml · nonDerivative · entry 4 MONTANOVA CAPITAL, LLC · CIK 0001569064 · Director Cowen Aaron · CIK 0001869640 · See footnotes Averill Master Fund, Ltd. · CIK 0001939329 · Director Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 612,033 F5 · shares: Notes are included on Exhibit 99.1. F6 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F5 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 22:11 UTC | Veradermics, Inc MANE · Entity 1907 | OtherCommon stock, par value $0.00001 per share | 149,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000947 · form4.xml · nonDerivative · entry 3 MONTANOVA CAPITAL, LLC · CIK 0001569064 · Director Cowen Aaron · CIK 0001869640 · See footnotes Averill Master Fund, Ltd. · CIK 0001939329 · Director Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,106,937 F4 · shares: Notes are included on Exhibit 99.1. F6 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F4 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 22:11 UTC | Veradermics, Inc MANE · Entity 1907 | SaleCommon stock, par value $0.00001 per share | 59,399 | $107.25 | $6,370,542.75 |
DisclosureSEC source: 0000899140-26-000947 · form4.xml · nonDerivative · entry 2 MONTANOVA CAPITAL, LLC · CIK 0001569064 · Director Cowen Aaron · CIK 0001869640 · See footnotes Averill Master Fund, Ltd. · CIK 0001939329 · Director Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 461,033 F3 · shares: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F3 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 22:11 UTC | Veradermics, Inc MANE · Entity 1907 | SaleCommon stock, par value $0.00001 per share | 690,601 | $107.25 | $74,066,957.25 |
DisclosureSEC source: 0000899140-26-000947 · form4.xml · nonDerivative · entry 1 MONTANOVA CAPITAL, LLC · CIK 0001569064 · Director Cowen Aaron · CIK 0001869640 · See footnotes Averill Master Fund, Ltd. · CIK 0001939329 · Director Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,957,937 F2 · shares: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F2 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| May 01, 2026 Filed May 6, 2026 01:37 UTC | Veradermics, Inc MANE · Entity 1907 | GrantPre-Funded Warrants · Derivative | 151,000 | $100.00 | $15,099,984.90 |
DisclosureSEC source: 0000899140-26-000415 · form4.xml · derivative · entry 2 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director Cowen Aaron · CIK 0001869640 · See footnotes Averill Master Fund, Ltd. · CIK 0001939329 · Director Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 151,000 Underlying: Common stock · 151,000 shares Expires not disclosed F4 · derivative.exercise_price: Notes are included on Exhibit 99.1. F3 · shares: Notes are included on Exhibit 99.1. F5 · derivative.exercise_date: Notes are included on Exhibit 99.1. F6 · derivative.exercise_date: Notes are included on Exhibit 99.1. F5 · derivative.expiration_date: Notes are included on Exhibit 99.1. F5 · derivative.underlying_shares: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F3 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| May 01, 2026 Filed May 6, 2026 01:37 UTC | Veradermics, Inc MANE · Entity 1907 | GrantPre-Funded Warrants · Derivative | 149,000 | $100.00 | $14,899,985.10 |
DisclosureSEC source: 0000899140-26-000415 · form4.xml · derivative · entry 1 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director Cowen Aaron · CIK 0001869640 · See footnotes Averill Master Fund, Ltd. · CIK 0001939329 · Director Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 149,000 Underlying: Common stock · 149,000 shares Expires not disclosed F4 · derivative.exercise_price: Notes are included on Exhibit 99.1. F2 · shares: Notes are included on Exhibit 99.1. F5 · derivative.exercise_date: Notes are included on Exhibit 99.1. F6 · derivative.exercise_date: Notes are included on Exhibit 99.1. F5 · derivative.expiration_date: Notes are included on Exhibit 99.1. F5 · derivative.underlying_shares: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F2 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 06, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 19,338 | $36.55 | $706,803.90 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 19 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 520,453 F20 · shares: Notes are included on Exhibit 99.1. F20 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F20 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 06, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 11,183 | $35.97 | $402,252.51 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 18 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 501,115 F19 · shares: Notes are included on Exhibit 99.1. F19 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F19 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 16,563 | $39.80 | $659,207.40 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 17 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 489,932 F18 · shares: Notes are included on Exhibit 99.1. F18 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F18 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 17,835 | $38.67 | $689,679.45 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 16 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 473,369 F17 · shares: Notes are included on Exhibit 99.1. F17 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F17 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 38,771 | $37.63 | $1,458,952.73 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 15 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 455,534 F16 · shares: Notes are included on Exhibit 99.1. F16 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F16 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 19,199 | $36.93 | $709,019.07 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 14 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 416,763 F15 · shares: Notes are included on Exhibit 99.1. F15 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F15 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 3,832 | $36.07 | $138,220.24 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 13 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 397,564 F14 · shares: Notes are included on Exhibit 99.1. F14 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F14 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 3,178 | $38.90 | $123,624.20 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 12 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 393,732 F13 · shares: Notes are included on Exhibit 99.1. F13 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F13 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 4,453 | $38.09 | $169,614.77 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 11 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 390,554 F12 · shares: Notes are included on Exhibit 99.1. F12 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F12 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 9,168 | $37.11 | $340,224.48 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 10 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 386,101 F11 · shares: Notes are included on Exhibit 99.1. F11 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F11 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 2,519 | $36.27 | $91,364.13 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 9 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 376,933 F10 · shares: Notes are included on Exhibit 99.1. F10 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F10 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 1,835 | $34.74 | $63,747.90 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 8 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 374,414 F9 · shares: Notes are included on Exhibit 99.1. F9 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F9 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 1,720 | $34.25 | $58,910.00 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 7 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 372,579 F8 · shares: Notes are included on Exhibit 99.1. F8 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F8 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 18,489 | $38.90 | $719,222.10 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 6 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,648,538 F7 · shares: Notes are included on Exhibit 99.1. F7 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F7 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 25,908 | $38.09 | $986,835.72 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 5 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,630,049 F6 · shares: Notes are included on Exhibit 99.1. F6 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F6 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 53,344 | $37.11 | $1,979,595.84 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 4 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,604,141 F5 · shares: Notes are included on Exhibit 99.1. F5 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F5 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 14,659 | $36.27 | $531,681.93 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 3 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,550,797 F4 · shares: Notes are included on Exhibit 99.1. F4 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F4 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 10,676 | $34.74 | $370,884.24 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 2 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,536,138 F3 · shares: Notes are included on Exhibit 99.1. F3 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F3 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| February 04, 2026 Filed Feb 9, 2026 23:28 UTC | Veradermics, Inc MANE · Entity 1907 | PurchaseCommon stock, par value $0.00001 per share | 10,004 | $34.25 | $342,637.00 |
DisclosureSEC source: 0000899140-26-000140 · form4.xml · nonDerivative · entry 1 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,525,462 F2 · shares: Notes are included on Exhibit 99.1. F2 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F2 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 00:31 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 11,587 | $13.44 | $155,729.28 |
DisclosureSEC source: 0000899140-25-001479 · form4.xml · nonDerivative · entry 6 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,848,156 F7 · shares: Notes are included on Exhibit 99.1. F7 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F7 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 00:31 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 65,800 | $13.44 | $884,352.00 |
DisclosureSEC source: 0000899140-25-001479 · form4.xml · nonDerivative · entry 5 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,700,195 F6 · shares: Notes are included on Exhibit 99.1. F6 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F6 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 26, 2025 Filed Dec 30, 2025 00:31 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 2,516 | $13.10 | $32,959.60 |
DisclosureSEC source: 0000899140-25-001479 · form4.xml · nonDerivative · entry 4 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,836,569 F5 · shares: Notes are included on Exhibit 99.1. F5 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F5 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 26, 2025 Filed Dec 30, 2025 00:31 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 14,320 | $13.10 | $187,592.00 |
DisclosureSEC source: 0000899140-25-001479 · form4.xml · nonDerivative · entry 3 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,634,395 F4 · shares: Notes are included on Exhibit 99.1. F4 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F4 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 00:31 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 7,400 | $12.85 | $95,090.00 |
DisclosureSEC source: 0000899140-25-001479 · form4.xml · nonDerivative · entry 2 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,834,053 F3 · shares: Notes are included on Exhibit 99.1. F3 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F3 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 00:31 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 42,600 | $12.85 | $547,410.00 |
DisclosureSEC source: 0000899140-25-001479 · form4.xml · nonDerivative · entry 1 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,620,075 F2 · shares: Notes are included on Exhibit 99.1. F2 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F2 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 00:45 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 2,892 | $12.08 | $34,935.36 |
DisclosureSEC source: 0000899140-25-001459 · form4.xml · nonDerivative · entry 6 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,826,653 F7 · shares: Notes are included on Exhibit 99.1. F7 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F7 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 00:45 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 16,650 | $12.08 | $201,132.00 |
DisclosureSEC source: 0000899140-25-001459 · form4.xml · nonDerivative · entry 5 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,577,475 F6 · shares: Notes are included on Exhibit 99.1. F6 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F6 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 19, 2025 Filed Dec 23, 2025 00:45 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 2,434 | $11.48 | $27,942.32 |
DisclosureSEC source: 0000899140-25-001459 · form4.xml · nonDerivative · entry 4 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,823,761 F5 · shares: Notes are included on Exhibit 99.1. F5 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F5 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 19, 2025 Filed Dec 23, 2025 00:45 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 13,950 | $11.48 | $160,146.00 |
DisclosureSEC source: 0000899140-25-001459 · form4.xml · nonDerivative · entry 3 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,560,825 F4 · shares: Notes are included on Exhibit 99.1. F4 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F4 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 18, 2025 Filed Dec 23, 2025 00:45 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 1,515 | $11.24 | $17,028.60 |
DisclosureSEC source: 0000899140-25-001459 · form4.xml · nonDerivative · entry 2 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,821,327 F3 · shares: Notes are included on Exhibit 99.1. F3 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F3 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 18, 2025 Filed Dec 23, 2025 00:45 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 8,700 | $11.24 | $97,788.00 |
DisclosureSEC source: 0000899140-25-001459 · form4.xml · nonDerivative · entry 1 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,546,875 F2 · shares: Notes are included on Exhibit 99.1. F2 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F2 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| November 07, 2025 Filed Nov 11, 2025 02:51 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 751,111 | $13.50 | $10,139,998.50 |
DisclosureSEC source: 0000899140-25-001256 · form4.xml · nonDerivative · entry 2 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,819,812 F3 · shares: Notes are included on Exhibit 99.1. F3 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F3 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| November 07, 2025 Filed Nov 11, 2025 02:51 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 730,370 | $13.50 | $9,859,995.00 |
DisclosureSEC source: 0000899140-25-001256 · form4.xml · nonDerivative · entry 1 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,538,175 F2 · shares: Notes are included on Exhibit 99.1. F2 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F2 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:37 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 670 | $13.22 | $8,857.40 |
DisclosureSEC source: 0000899140-25-000486 · form4.xml · nonDerivative · entry 4 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,068,701 F5 · shares: Notes are included on Exhibit 99.1. F5 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F5 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:37 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 5,057 | $13.22 | $66,853.54 |
DisclosureSEC source: 0000899140-25-000486 · form4.xml · nonDerivative · entry 3 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 8,807,805 F4 · shares: Notes are included on Exhibit 99.1. F4 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F4 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:37 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 1,267 | $12.63 | $16,002.21 |
DisclosureSEC source: 0000899140-25-000486 · form4.xml · nonDerivative · entry 2 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,068,031 F3 · shares: Notes are included on Exhibit 99.1. F3 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F3 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:37 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 9,503 | $12.63 | $120,022.89 |
DisclosureSEC source: 0000899140-25-000486 · form4.xml · nonDerivative · entry 1 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 8,802,748 F2 · shares: Notes are included on Exhibit 99.1. F2 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F2 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:51 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 106,200 | $13.00 | $1,380,600.00 |
DisclosureSEC source: 0000899140-25-000479 · form4.xml · nonDerivative · entry 2 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,066,764 F3 · shares: Notes are included on Exhibit 99.1. F3 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F3 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:51 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 793,800 | $13.00 | $10,319,400.00 |
DisclosureSEC source: 0000899140-25-000479 · form4.xml · nonDerivative · entry 1 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 8,793,245 F2 · shares: Notes are included on Exhibit 99.1. F2 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F2 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 24, 2024 Filed Dec 26, 2024 21:28 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 2,288 | $11.25 | $25,740.00 |
DisclosureSEC source: 0000899140-24-001385 · form4.xml · nonDerivative · entry 4 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 960,554 F5 · shares: Notes are included on Exhibit 99.1. F5 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F5 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 24, 2024 Filed Dec 26, 2024 21:28 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 17,730 | $11.25 | $199,462.50 |
DisclosureSEC source: 0000899140-24-001385 · form4.xml · nonDerivative · entry 3 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 7,999,455 F4 · shares: Notes are included on Exhibit 99.1. F4 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F4 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:28 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon stock, par value $0.0001 per share | 3,142 | $10.98 | $34,499.16 |
DisclosureSEC source: 0000899140-24-001385 · form4.xml · nonDerivative · entry 2 SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064 · Director · 10% owner Averill Madison Master Fund, Ltd. · CIK 0002021243 · Director · 10% owner Averill Master Fund, Ltd. · CIK 0001939329 · Director · 10% owner Cowen Aaron · CIK 0001869640 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 958,266 F3 · shares: Notes are included on Exhibit 99.1. F3 · price: Notes are included on Exhibit 99.1. F1 · ownership.direct: Notes are included on Exhibit 99.1. F1 · ownership.nature: Notes are included on Exhibit 99.1. F3 · ownership.nature: Notes are included on Exhibit 99.1. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.